type of [0.6%):99% Proguanil: 75% Special Populations: Renal Function Impairment In patients with moderate renal impairment (CrCl 30-50 mL/minute), mean oral clearance for proguanil was reduced by ~35% compared with patients with normal renal function CrCl >80 mL/minute). In patients with severe renal impairment (CrCl] Drug Status Rx Availability Prescription only C Pregnancy Category Risk cannot be ruled out N/A CSA Schedule Not a controlled drug Approval History Drug history at FDA Atovaquone / proguanil Rating 24 User Reviews 5.9 /10 24 User Reviews 5.9 Rate it! Manufacturers Mylan Pharmaceuticals Inc. Prasco Laboratories Glenmark Pharmaceuticals Inc., USA Drug Class Antimalarial combinations Related Drugs antimalarial combinations Malarone , atovaquone / proguanil , pyrimethamine / sulfadoxine , artemether / lumefantrine , Fansidar , Malarone Pediatric Malaria Prevention doxycycline , hydroxychloroquine , Plaquenil , Vibramycin , Malarone , Monodox , mefloquine , atovaquone / proguanil , Doryx , pyrimethamine , More... Malaria doxycycline , hydroxychloroquine , clindamycin , Plaquenil , Cleocin , Vibramycin , quinine , Malarone , atovaquone , Monodox , quinidine , More... Atovaquone / proguanil Images Atovaquone / proguanil systemic 250 mg / 100 mg (G 404) View all images xmas
a hundred and fortieth Atovaquone and Proguanil a chronic
EmoticonEmoticon